| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 393,3 k € | -84.7% | 2,6 M € | -6.8% | 2,7 M € | +13.3% | 2,4 M € | +64.6% | 1,5 M € | +40.5% | 1,0 M € | +32.7% | 790,5 k € | +2.5% | 770,9 k € | +973.4% | 71,8 k € | +118.2% | -394,6 k € | |
| EBITDA | -1,8 M € | -764.4% | 269,6 k € | -73.4% | 1,0 M € | +54.2% | 658,1 k € | +59.2% | 413,5 k € | +0.9% | 409,6 k € | +15.7% | 354,0 k € | -23.1% | 460,5 k € | +696.5% | -77,2 k € | +86.2% | -557,6 k € | |
| Operating profit | -2,7 M € | -768.5% | -306,7 k € | -191.0% | 336,9 k € | +1089.1% | -34,1 k € | +80.8% | -177,8 k € | -33.4% | -133,3 k € | -285.8% | -34,5 k € | -119.1% | 181,3 k € | +197.6% | -185,8 k € | +70.4% | -628,3 k € | |
| Profit/loss | -3,0 M € | -1017.7% | -266,3 k € | -158.1% | 458,5 k € | +92.6% | 238,0 k € | +6259.3% | -3,9 k € | -139.4% | 9,8 k € | -81.1% | 52,0 k € | -72.4% | 188,5 k € | +194.0% | -200,5 k € | +68.8% | -641,6 k € | |
| Equity | -1,6 M € | -214.1% | 1,4 M € | -20.5% | 1,8 M € | +21.5% | 1,5 M € | +0.3% | 1,5 M € | +9.0% | 1,3 M € | +15.8% | 1,1 M € | +35.9% | 845,2 k € | +48.8% | 568,1 k € | +2279.4% | 23,9 k € | |
| Total assets | 9,6 M € | -11.7% | 10,8 M € | +62.8% | 6,7 M € | +26.0% | 5,3 M € | +73.3% | 3,0 M € | +14.4% | 2,7 M € | -2.4% | 2,7 M € | +28.2% | 2,1 M € | +102.1% | 1,1 M € | +73.9% | 606,1 k € | |
| Cash | 1,5 M € | -15.3% | 1,8 M € | +194.9% | 605,2 k € | +7.4% | 563,6 k € | +82.3% | 309,2 k € | -15.4% | 365,6 k € | +15.2% | 317,4 k € | -54.3% | 694,2 k € | +49.1% | 465,7 k € | +94.9% | 239,0 k € | |
| Debts | 11,0 M € | +16.6% | 9,4 M € | +149.5% | 3,8 M € | +0.6% | 3,8 M € | +198.6% | 1,3 M € | +13.5% | 1,1 M € | -6.0% | 1,2 M € | -7.6% | 1,3 M € | +165.3% | 481,7 k € | -16.7% | 578,6 k € | |
| Staff | 26,7 | 24,6 | 22 | 18,3 | 13,2 | 10 | 7,4 | — | — | 1,9 | ||||||||||
Public limited company · Charleroi · incorporated on 16/05/2014 · 26,7 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-15.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
ImmunXperts is a Public limited company incorporated in 2014. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Charleroi. It employs on average 26,7 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette